Transaction · 0001425450-26-000081

Pelizzon David R

Pelizzon David R, DIR, reported an open-market or private sale at ORTHOPEDIATRICS CORP involving 4000.000000 shares for an estimated $103000.00. Reported holdings after the transaction were 6897764.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
KIDSORTHOPEDIATRICS CORP
Trade date
Aug 24, 2026
Filing date
Aug 26, 2026
View on SEC Insider profile
Estimated value-$103kShares × reported price
Shares traded4.00k$25.75 per share
Holdings after6.89MIndirect · See footnote
% of reported position traded0.06%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 6,901,764 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

KIDS price since this filing

Daily closing prices, with the filing date and available return windows
KIDS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d -5.1%30d -6.2%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001425450-26-000081
Common Stock
Transaction date
Aug 24, 2026
Filed Aug 26, 2026, 10:17 PM · 2d delay
Shares
4,000 sh
$25.75 per share
Estimated value
-$103k
Computed from shares × price
Holdings after
6,897,764 sh
Indirect · See footnote
Filing-only score

+4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82,

  3. inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission,

  4. upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

  5. F3

    These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these…

  6. F4

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provi…

  7. F5

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provi…

  8. F6

    Includes restricted stock awards totaling 17,959 shares.

Original filing · 0001425450-26-000081
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

KIDS